News
The candidate fell short in a phase 2 psoriasis trial, prompting the French drugmaker to pull back from plans to develop the molecule as a monotherapy. Led by AbbVie’s Humira, biologic TNF ...
However, the analyst contends that three of the four misses in today’s Phase 2 are “narrow – and will quite likely be ok” in a larger Phase 3 trial. The firm maintains an Outperform rating ...
Phase 2 will raise Northern Lights’ capacity from 1.5 million metric tons per annum (MMtpa) to over 5 MMtpa. The expansion will leverage existing onshore and offshore infrastructures and install ...
Construction on the U.S. 31 project in Franklin began on April 7 and will continue until summer 2028. JOHNSON COUNTY – Indiana Department of Transportation contractor Milestone Contractors is ...
Bioxodes has stopped enrolling people in a phase 2a stroke study after hitting the safety and efficacy endpoints, positioning the Belgian biotech to power into a potentially registrational trial.
The Phase 2 trial is a multi-center, single-arm, two-stage, open-label study designed to evaluate the safety and efficacy of MB-105 in patients with relapsed or refractory CD5-positive T-cell lymphoma ...
The registration deadline for Round 2 of the Prime Minister Internship Scheme 2025 has been extended to April 15, giving students and young professionals more time to apply. The scheme offers year ...
LAWRENCE COUNTY, Ohio (WSAZ) - The Ohio Department of Transportation District 9 is celebrating the beginning of construction on phase 2 of the State Route 7 Chesapeake Bypass project.
A Phase 2 trial demonstrated that the DPP-1 inhibitor HSK31858 significantly reduces acute exacerbations in non-cystic fibrosis bronchiectasis patients compared to placebo, with a 48% reduction at ...
The proposed Brookfield Reserve Phase 2 would replace an office building with 210 apartments and co-working space. An informational meeting for residents will be held April 29, with a Plan ...
ORLANDO, Fla. — A second phase 2 trial with the tyrosine kinase 2 (TYK2) inhibitor deucravacitinib has met the primary efficacy endpoints for the treatment of the skin manifestations of ...
POTOMAC, MD / ACCESS Newswire / April 1, 2025 / IGC Pharma, Inc. (NYSE American:IGC) today announced the expansion of its Phase 2 clinical trial, CALMA, evaluating IGC-AD1 for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results